| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.007 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |